Skip to main content
. 2017 May 18;23:2333–2339. doi: 10.12659/MSM.904206

Figure 1.

Figure 1

The ROC curve of MPA-AUC for short-term outcomes of MMF and GC treatment in children with HSPN. The predictive value of MPA-AUC in short-term outcomes of MMF and GC treatment in HSPN children were evaluated by receiver operating characteristics curve. The area under the ROC curve of MPA-AUC was 0.731 with the optimal cut-off value of μg·h/ml (sensitivity: 85.2%; specificity: 64.3%).